Surgical treatment of “intermediate risk” lymph node negative cervical cancer patients without adjuvant radiotherapy—A retrospective cohort study and review of the literature-Reference-Cited by-同舟云学术

Surgical treatment of “intermediate risk” lymph node negative cervical cancer patients without adjuvant radiotherapy—A retrospective cohort study and review of the literature

Published:2018-12 Issue:3 Volume:151 Page:438-443
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Cibula David^ORCID,Abu-Rustum Nadeem R.,Fischerova Daniela,Pather Selvan^ORCID,Lavigne Katie,Slama Jiri,Alektiar Kaled,Ming-Yin Lin,Kocian Roman,Germanova Anna,Frühauf Filip,Dostalek Lukas^ORCID,Dusek Ladislav,Narayan Kailash^ORCID

Funder

Charles University in Prague

Ministry of Health of the Czech Republic

Czech Research Council

NIH/NCI Cancer Center

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference19 articles.

1. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study;Sedlis;Gynecol. Oncol.,1999

2. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study;Rotman;Int. J. Radiat. Oncol. Biol. Phys.,2006